A novel selective VPAC2 agonist peptide-conjugated chitosan modified selenium nanoparticles with enhanced anti-type 2 diabetes synergy effects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel selective VPAC2 agonist peptide-conjugated chitosan modified selenium nanoparticles with enhanced anti-type 2 diabetes synergy effects

Published:2017-03 Issue: Volume:Volume 12 Page:2143-2160
ISSN:1178-2013
Container-title:International Journal of Nanomedicine
language:en
Short-container-title:IJN

Author:

Zhao Shaojun,Wang Dehua,Li Yanwei,Han Lei,Xiao Xing,Ma Min,Wan David Chi-Cheong,Hong An,Ma Yi

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,General Medicine,Biomaterials,Bioengineering,Biophysics,Pharmaceutical Science

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Selenium Nanoparticles in Addressing Diabetic Complications: A Comprehensive Study;Current Topics in Medicinal Chemistry;2024-06

2. Microbial-Based Biotechnology: Production and Evaluation of Selenium-Tellurium Nanoalloys;Applied Sciences;2023-10-26

3. Biogenic Selenium Nanoparticles in Biomedical Sciences: Properties, Current Trends, Novel Opportunities and Emerging Challenges in Theranostic Nanomedicine;Nanomaterials;2023-01-19

4. Chitosan-based selenium composites as potent Se supplements: Synthesis, beneficial health effects, and applications in food and agriculture;Trends in Food Science & Technology;2022-11

5. Therapeutic potential of vasoactive intestinal peptide and its receptor VPAC2 in type 2 diabetes;Frontiers in Endocrinology;2022-09-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP